Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001583104 | SCV001810693 | likely pathogenic | not provided | 2021-02-22 | criteria provided, single submitter | clinical testing | Also reported in an individual with Parkinson disease who was heterozygous for this variant, however, information regarding parental testing was not available (Noreau et al., 2011).; In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Also reported as W378G due to alternate nomenclature; This variant is associated with the following publications: (PMID: 33176831, 29920646, 21856586, 26995357, 23079555, 8790604, 24219755) |
Fulgent Genetics, |
RCV002488413 | SCV002792186 | pathogenic | Lewy body dementia; Gaucher disease type I; Gaucher disease type II; Gaucher disease type III; Gaucher disease perinatal lethal; Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome; Parkinson disease, late-onset | 2021-09-21 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV001583104 | SCV005439161 | pathogenic | not provided | 2023-10-16 | criteria provided, single submitter | clinical testing | PP3, PP4, PM2_moderate, PM3_strong, PS4_moderate |
Natera, |
RCV001827516 | SCV002086457 | likely pathogenic | Gaucher disease | 2020-12-18 | no assertion criteria provided | clinical testing |